期刊文献+

Skp2和P27在上皮性卵巢癌中表达及其临床意义 被引量:1

Skp2 and P27 Expression in Epithelial Ovarian Carcinoma and Their Significances
原文传递
导出
摘要 目的:检测Skp2和P27在上皮性卵巢癌中的表达,分析Skp2和P27与临床病理特征间的关系,探讨二者在上皮性卵巢癌发生发展中的作用。方法:应用免疫组织化学SP法,检测69例上皮性卵巢癌、15例良性卵巢肿瘤以及15例正常卵巢组织中Skp2和P27的表达,分析Skp2和P27表达与上皮性卵巢癌临床病理参数的关系,及两者的相关性。结果:上皮性卵巢癌、良性卵巢肿瘤及正常卵巢组织Skp2和P27表达阳性率各为42.02%,26.67%、6.67%和47.82%,66.67%、86.67%,差异有统计学意义(P<0.05)。Skp2的表达与临床分期和病理组织学分级显著相关,与患者年龄、病理类型、有无淋巴结转移和肿瘤大小无显著相关。P27的表达与临床分期、有无淋巴结转移和病理组织学分级显著相关,与患者年龄、病理类型和肿瘤大小无显著相关。Skp2和P27在上皮性卵巢癌中表达呈显著负相关,相关系数r=-0.463,(P<0.01)。结论:Skp2与P27呈负相关,二者表达可能与上皮性卵巢癌的发生发展有关。 Objective: To investigate the expression of Skp2 and P27 in primary ovarian cancer, and their relationship with clinicpathologic characters, and the correlation between expression of Skp2 and P27 in primary ovarian cancer. Methods: Paraffin-embedded tissue specimens from 69 case s of primary ovarian cancer, 15 cases of benign ovarian tumor and 15 cases of normal ovarian tissue were examined by monoclonal antibody of Skp2 and P27 with immunohistochemical technique (SP staining). The correlations between Skp2 and P27 expression and several clinicopathological parameters were assessed. Results: The expression rates of Skp2 and P27 in ovarian cancers,benign ovarian tumor and normal tissues is 42.02%, 26.67%, 6.67% and 47.82%, 66.67%, 86.67%. There were obvious differences of Skp2 among the three groups (P〈0.05). Skp2 expression was significantly associated with clinical stage and histological grade, but not associated with lymph node metastasis, histological types and sizes of primary ovarian cancer and age of the patients. P27 expression was significantly associated with clinical stage, histological grade and lymph node metastasis, but not with histological types and sizes of primary ovarian cancer and age of the patients. Skp2 was inversely associated with expression of P27 in primary ovarian cancer. (r=-0.463, P〈0.01). Conclusion: The results implied that expression of Skp2 may be correlation to carcinogenesis and development of primary ovarian cancer.cyclin-deoended kinase inbitor P27 proteolvsis may be correlated with the expression of Skp2.
出处 《现代生物医学进展》 CAS 2009年第18期3481-3483,3501,共4页 Progress in Modern Biomedicine
关键词 卵巢肿瘤 SKP2 P27 免疫组织化学染色 ovarian cancer Skp2 P27 immunohistochemical technique
  • 相关文献

参考文献9

  • 1Hashimoto N, Yachida S, Okano K, et al. Immunohistochemically detected expression ofp27(Kipl) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas [J]. Ann Surg Oncol, 2009,16(2):395-403.
  • 2Liu Z, Fu Q, Lv ,I, et al. Prognostic implication of p27Kipl, Skp2 and Cksl expression in renal cell carcinoma: a tissue microarray study[J].J Exp Clin Cancer Res, 2008, 15:27:51.
  • 3Okada M, Sakai T, Nakamura T, et al. Skp2 promotes adipocyte differentiation via a p27Kipl-independent mechanism ill primary mouse embryonic fibroblasts[J]. Biochem Biophys Res Commun. 2009, 379 (2):249-54.
  • 4Liu Y, Perdreau SA, Chatterjce P, et al. hnatinib mesylate induces quiescence in gastrointestinal stromal tumor cells through the CDHI-SKP2-p27Kipl signaling axis [J]. Cancer Res, 2008.68(21): 9015-23.
  • 5Uddin S, Hussam A, Ahmed M, et al. S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma[J]. J Pathol, 2008, 216(4):483-94.
  • 6Yachida S. Sakamoto M, lmaida K, et al. p27(Kipl )is overexpressed in very. early stages of hepatocarcinogenesis[J]., 2008, 99(11):2152-9.
  • 7Yokoi S, Yasui K. Mori M, et al. Amplification and over-expression of Skp2 arc associated with metastasis of non-small-cell lung cancers to lymph nodes[J]. Am J Pathol,2004,165 ( 1 ) :175-180.
  • 8Hulit J. Lee RJ, Li Z. et al. p27Kip1 repression of ErbB2-mduced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling[J]. Cancer Res, 2006, 66(17):8529-41.
  • 9Hashimoto N, Yachida S, Okano K, et al. lmmunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas [J]. Ann Surg Oncol, 2009, 16 (2):395-403.

同被引文献6

  • 1陈睿,汪蕊,杨婉华,马湘一,卢运萍,王世宣,马丁.CD44v6和LYVE-1蛋白在卵巢上皮性肿瘤中的表达及意义[J].肿瘤防治研究,2006,33(10):704-706. 被引量:1
  • 2Slaz W,Eisenberg D,Plescia J,et al.A survivin gene signature predicts aggressive tumor behavior[J].Cancer Res,2005,65 (9):3531.
  • 3Sui L,Dong Y,Ohno M,et al.Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors[J].Int J Oncol,2002,21(2):315-320.
  • 4Sheridan E,Silcoeks P,Srnith J,et al.p53 mutation in a series of epithelial ovarian cancer from the U.K,and its prognostic significance[J].Eur J Cancer,1994,30A(11):1071-1074.
  • 5Nakeyama K,Tokebayashi Y,Nakayama S,et al.Progonostic value of over expression of p53 in human ovarian carcinoma patients receiving cisplatin[J].Cancer Left,2003,192:227-335.
  • 6王英芳.上皮性卵巢癌组织中P53和Survivin蛋白的表达[J].郑州大学学报(医学版),2007,42(5):935-937. 被引量:6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部